Biohaven (BHVN) Closes IPO Offering, Raises $193.5 Million

By |May 12th, 2017|

Biohaven Pharmaceuticals Holding Co Ltd (NYSE: BHVN)

Biohaven (BHVN) today announced that the company has officially closed its IPO, raising $193.5 million before deducting underwriting discounts, fees, and commissions. As a result of the full exercise of underwriters options, the total public offering size was 11,385,000 shares of common stock.
BHVN Has Momentum
BHVN was a featured stock of […]